Literature DB >> 6862461

Chemotherapy of Amanita phalloides poisoning with intravenous silibinin.

K Hruby, G Csomos, M Fuhrmann, H Thaler.   

Abstract

1 A total of 18 cases of Amanita phalloides intoxication was treated by combined chemotherapy during 1980 and 1981. After attempted primary elimination of the toxin all patients received silibinin as basic therapy mainly by infusion and in two instances orally. 2 In order to evaluate the effect of silibinin therapy a retrospective study of the followed-up case records was made. The cases were arbitrarily classified into three groups according to the severity of liver damage (light, medium and severe). 3 There was found a close relationship between the severity of liver injury and the delay between mushroom ingestion and the onset of silibinin therapy. With the exception of one fatality in a particularly high dosage suicidal intoxication, all patients survived. 4 Administration of silibrinin even up to 48 h after mushroom ingestion appears to be an effective measure to prevent severe liver damage in Amanita phalloides poisoning. Contrarily, the onset of general supportive treatment together with penicillin therapy which was throughout several hours before silibinin administration did not correlate with the severity of liver damage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6862461     DOI: 10.1177/096032718300200203

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  15 in total

1.  Adverse reactions to watch for in patients using herbal remedies.

Authors:  R Ko
Journal:  West J Med       Date:  1999-09

2.  Letters to the editor.

Authors:  Ronald G Amedee
Journal:  Ochsner J       Date:  2014

3.  Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 4.  Treatment of human amatoxin mushroom poisoning. Myths and advances in therapy.

Authors:  G L Floersheim
Journal:  Med Toxicol       Date:  1987 Jan-Feb

Review 5.  The use of silymarin in the treatment of liver diseases.

Authors:  R Saller; R Meier; R Brignoli
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Is there any use for nontraditional or alternative therapies in patients with chronic liver disease?

Authors:  N M Bass
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

7.  Acute liver failure: a management challenge for the practicing gastroenterologist.

Authors:  Dawn McDowell Torres; Robert D Stevens; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

8.  Protection against Amanita phalloides by the iridoid glycoside mixture of Picrorhiza kurroa (kutkin).

Authors:  G L Floersheim; A Bieri; R Koenig; A Pletscher
Journal:  Agents Actions       Date:  1990-03

Review 9.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

10.  Comparative pharmacokinetics of silipide and silymarin in rats.

Authors:  P Morazzoni; A Montalbetti; S Malandrino; G Pifferi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.